Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02069288

Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock

Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response, Gastric Mucosal Perfusion and Arterial Stiffness in Septic Shock

Status
Withdrawn
Phase
Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Septic shock (associated with relative adrenal insufficiency) is characterized by decreased arterial responsiveness to catecholamines. The association of hydrocortisone and fludrocortisone has demonstrated an improvement in survival in septic shock patients. If hydrocortisone has shown to increase vascular responsiveness, the role of fludrocortisone remains to be elucidated. The purpose of our study is to investigate the effect of a physiological dose of fludrocortisone alone on norepinephrine-mean arterial pressure dose-response relationship, gastric mucosal perfusion and arterial stiffness in patients with septic shock.

Conditions

Interventions

TypeNameDescription
DRUGFludrocortisone50 µg of fludrocortisone per os
DRUGPlacebo1 tablet of placebo per os

Timeline

Primary completion
2014-02-01
Completion
2014-02-01
First posted
2014-02-24
Last updated
2014-02-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02069288. Inclusion in this directory is not an endorsement.